FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancerXiaoyong Fu, Rachel Schiff, Pavana Anur et al.|Proceedings of the National Academy of Sciences|2016Cited by 185
High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancerXiaoyong Fu, Rachel Schiff, Resel Pereira et al.|Cell Reports|2023Cited by 20
Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft modelsJamunarani Veeraraghavan, Rachel Schiff, Carolina Gutiérrez et al.|npj Breast Cancer|2021Cited by 11
Abstract P3-06-07: ADGRF1 overexpression inhibits tumor growth <i>in vivo</i> by inducing cell cycle arrest in HER2+ breast cancerRaksha R. Bhat, Meghana V. Trivedi, Noor Mazin Abdulkareem et al.|Cancer Research|2020Cited by 0
High FOXA1 Levels Induce ER Transcriptional Reprogramming and Promote a Pro-Metastatic Secretome and Metastasis in Endocrine-Resistant Breast CancerXiaoyong Fu, Rachel Schiff, Resel Pereira et al.|SSRN Electronic Journal|2021Cited by 0